VivaLNK Partners with Emory University to Provide Wearable ECG Sensors for Study

VivaLNK, a Campbell, CA-based connected healthcare solutions provider, teamed up with....

Image: VivaLNK

VivaLNK, a Campbell, CA-based connected healthcare solutions provider, teamed up with Emory University to provide its medical wearable ECG sensors for a study to evaluate autonomic function in predicting coronary artery disease (CAD) and its relationship to depression and long-term outcomes. The study builds upon previous work by Emory researchers titled Circadian Autonomic Inflexibility: A Marker of Ischemic Heart Disease, which associates lower heart rate variability (HRV) with subclinical myocardial ischemia.

Read more VivaLNK Offers its Wearable Healthcare Devices to Stanford University for Study on Stress and Teenage Depression

The VivaLNK ECG patch contains a sensor and accelerometer to capture and generate multiple physiological data including ECG trace, heart rate, RR-interval, and 3-axis motion. About the size of a small bandage, the reusable and rechargeable patch weighs a mere 7.5 grams, and can be worn continuously for 72 hours at-a-time to capture and transmit data in real time, the company said in a press release.

“VivaLNK's ECG patch is very small and comfortable to wear, which are important factors for clinical use and long-term ECG monitoring,” said Amit Shah, MD, Assistant Professor of Epidemiology at the Rollins School of Public Health at Emory University. “In addition, the software development kit makes it easy to use the patch for research and product development purposes.”

Image: Emory University

The researchers will use the device to remotely monitor patients who are undergoing coronary angiography, in order to measure autonomic function. Participants will be monitored using the ECG patch for continuous 72-hour periods in a clinical and ambulatory environment, which offers a more complete picture in a natural setting.

Read more Apple Joins Eli Lilly to Study How iPhone and Apple Watch Can Detect Signs of Dementia

The goal is to better understand the role of the autonomic nervous system in depression and coronary artery disease, and to develop better tools for clinical assessment.

VivaLNK provides connected healthcare solutions for wellness, patient care, and telemedicine. The company's portfolio includes wearable medical grade devices and data analytics applications that continuously monitor the health and well-being of individuals.

Sam Draper
September 10, 2019

Innovation of the Month

Do you want to discover more, visit the website
Visit Website

Other news

This Wearable Insole Could Prevent Shin Splints Forever

The term "shin splints" refers to pain along the shin bone, also known as the tibia. It is the...

How AI-Enabled Wearables Are Changing the Way Healthcare Diagnoses Are Conducted

Artificial Intelligence (AI) is becoming more and more sophisticated at imitating humans,but more...

UK Virtual Reality Startup Moonhub Launches VR Dementia Training Suite

Virtual Reality (VR) startup Moonhub has launched an immersive VR platform used to train social...

New Wireless Magnetic Phone Charger

Ossia and Toyoda Gosei will launch Cota Forever, a new magnetic wireless phone charger at the CES.
Discover more